Clinical trial
A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma…
NCT00283504 · Children's Hospital of The King's Daughters, Other · Completed
Key facts
| NCT number | NCT00283504 |
|---|---|
| Title | A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy |
| Official title | A Description of Inflammatory Cell Types in Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy (Xolair) |
| Lead sponsor | Children's Hospital of The King's Daughters, Other |
| Collaborators | Novartis Industry Genentech, Inc. |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ALLERGIC ASTHMA |
| Intervention type | Drug |
| Interventions | ANTI-IGE THERAPY (XOLAIR) |
| Enrollment | 13 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 30, 2006 |
| Last update posted | Feb 19, 2018 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: